Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Development of telemedicine in the Czech Republic from patients' and other key stakeholders' perspective

JK. Těšinová, K. Dobiášová, Z. Dušek, A. Tobiášová

. 2023 ; 11 (-) : 1202182. [pub] 20231023

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Telemedicine is a way to improve healthcare outcomes with greater efficiency for both patients and care providers. The great potential of digital technologies also lies in strengthening the patient-centered approach. The early successes and benefits of telemedicine in the Czech Republic, amplified by the COVID-19, have contributed to the fact that wider implementation of telemedicine is already generally supported at the expert and public levels. Our research focuses on the identification of key issues in the implementation of telemedicine and the challenges of telemedicine in the future, from the perspective of patients and other stakeholders. The study is based on a qualitative research approach, combining focus groups with key stakeholders, patient panels and expert panels (2021-2022). The lack of rules and uncoordinated development of various activities proved to be the main barriers to the integration of telemedicine in the health system. This regulatory uncertainty can generate a number of problems in the patient-doctor relationship in practice, including ethical ones, and can also lead to inequalities in access to healthcare and affect the overall quality of care provided. Furthermore, it has been shown that patients' interests in the implementation of telemedicine are: 1. a predictable and reliable framework that guarantees them certainty and security in the provision of telemedicine services, 2. telemedicine solutions that increase the availability and efficiency of the care provided while bringing comfort, and 3. user-friendly and simple solutions. At the same time, patients want to understand the new environment and be active participants in the process of digital innovation, including the practical implementation of telemedicine. The research team has developed recommendations for further developments in the implementation of telemedicine that reflect the patient's interest and can be implemented at three levels - the health system, institutional, and community level. In countries with a well-developed and institutionalized patient movement, the community level can be represented by patient organizations, thus becoming the link between telemedicine policy making and implementation at the individual level of healthcare provision. For the further development of telemedicine, the development of a national strategy involving all key stakeholders, including patients, in the implementation has proven essential.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24001000
003      
CZ-PrNML
005      
20250429134153.0
007      
ta
008      
240109e20231023sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fpubh.2023.1202182 $2 doi
035    __
$a (PubMed)37937075
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Těšinová, Jolana Kopsa $u Institute of Public Health and Medical Law, First Faculty of Medicine, Charles University, Prague, Czechia
245    10
$a Development of telemedicine in the Czech Republic from patients' and other key stakeholders' perspective / $c JK. Těšinová, K. Dobiášová, Z. Dušek, A. Tobiášová
520    9_
$a Telemedicine is a way to improve healthcare outcomes with greater efficiency for both patients and care providers. The great potential of digital technologies also lies in strengthening the patient-centered approach. The early successes and benefits of telemedicine in the Czech Republic, amplified by the COVID-19, have contributed to the fact that wider implementation of telemedicine is already generally supported at the expert and public levels. Our research focuses on the identification of key issues in the implementation of telemedicine and the challenges of telemedicine in the future, from the perspective of patients and other stakeholders. The study is based on a qualitative research approach, combining focus groups with key stakeholders, patient panels and expert panels (2021-2022). The lack of rules and uncoordinated development of various activities proved to be the main barriers to the integration of telemedicine in the health system. This regulatory uncertainty can generate a number of problems in the patient-doctor relationship in practice, including ethical ones, and can also lead to inequalities in access to healthcare and affect the overall quality of care provided. Furthermore, it has been shown that patients' interests in the implementation of telemedicine are: 1. a predictable and reliable framework that guarantees them certainty and security in the provision of telemedicine services, 2. telemedicine solutions that increase the availability and efficiency of the care provided while bringing comfort, and 3. user-friendly and simple solutions. At the same time, patients want to understand the new environment and be active participants in the process of digital innovation, including the practical implementation of telemedicine. The research team has developed recommendations for further developments in the implementation of telemedicine that reflect the patient's interest and can be implemented at three levels - the health system, institutional, and community level. In countries with a well-developed and institutionalized patient movement, the community level can be represented by patient organizations, thus becoming the link between telemedicine policy making and implementation at the individual level of healthcare provision. For the further development of telemedicine, the development of a national strategy involving all key stakeholders, including patients, in the implementation has proven essential.
650    _2
$a lidé $7 D006801
650    12
$a telemedicína $7 D017216
650    _2
$a poskytování zdravotní péče $7 D003695
650    _2
$a pacienti $7 D010361
650    12
$a COVID-19 $x epidemiologie $7 D000086382
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Dobiášová, Karolína, $d 1970- $u Institute of Public Health and Medical Law, First Faculty of Medicine, Charles University, Prague, Czechia $7 mzk2006324009
700    1_
$a Dušek, Zdeněk $u Ernst & Young, s.r.o, Prague, Czechia
700    1_
$a Tobiášová, Alena $u Institute of Public Health and Medical Law, First Faculty of Medicine, Charles University, Prague, Czechia
773    0_
$w MED00186211 $t Frontiers in public health $x 2296-2565 $g Roč. 11 (20231023), s. 1202182
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37937075 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20250429134149 $b ABA008
999    __
$a ok $b bmc $g 2049552 $s 1210694
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 11 $c - $d 1202182 $e 20231023 $i 2296-2565 $m Frontiers in public health $n Front Public Health $x MED00186211
LZP    __
$a Pubmed-20240109

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...